Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $150.1500 (2.67%) ($150.1500 - $150.1500) on Thu. Feb. 25, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.82% (three month average) | RSI | 39 | Latest Price | $150.1500(2.67%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND advances 0.7% a day on average for past five trading days. | Weekly Trend | LGND declines -16% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(59%) IWO(58%) IWM(54%) IWC(53%) XBI(53%) | Factors Impacting LGND price | LGND will decline at least -2.41% in a week (0% probabilities). VIXM(-28%) UUP(-18%) VXX(-17%) UNG(-3%) TBT(-1%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.41% (StdDev 4.82%) | Hourly BBV | 0.7 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $121.24(-19.25%) | Resistance Level | $171.72 | 5 Day Moving Average | $144.21(4.12%) | 10 Day Moving Average | $152.11(-1.29%) | 20 Day Moving Average | $171.72(-12.56%) | To recent high | -30.4% | To recent low | 79.9% | Market Cap | $2.413b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |